These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 7491691
21. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants. Chen G, Sun QY, Wang XM, Shen SQ, Guo H, Wang H, Wu Y, Wang WY, Xiong YL, Chen S. Xenotransplantation; 2004 Mar; 11(2):123-32. PubMed ID: 14962274 [Abstract] [Full Text] [Related]
22. Hyperacute xenograft rejection in the guinea pig to rat heart transplantation model. Bouwman E, Loonen EM, Wolvekamp M, de Bruin RW, Jeekel J, Marquet RL. Transplant Proc; 1990 Jun; 22(3):1063-4. PubMed ID: 2349662 [No Abstract] [Full Text] [Related]
23. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation. Chen D, Cao R, Guo H, Chen G, Wang X, Shen S, Chen S. Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288 [Abstract] [Full Text] [Related]
24. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model. Brandl U, Michel S, Erhardt M, Brenner P, Bittmann I, Rössle M, Baschnegger H, Bauer A, Hammer C, Schmoeckel M, Reichart B. Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844 [Abstract] [Full Text] [Related]
25. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection. Malassagne B, Regimbeau JM, Taboit F, Troalen F, Chéreau C, Moiré N, Attal J, Batteux F, Conti F, Calmus Y, Houssin D, Boulard C, Houdebine LM, Weill B. Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547 [Abstract] [Full Text] [Related]
26. Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity. Xia G, Ji P, Rutgeerts O, Waer M. Transplantation; 2000 Jul 15; 70(1):86-93. PubMed ID: 10919580 [Abstract] [Full Text] [Related]
27. Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts. Brauer RB, Baldwin WM, Pruitt SK, Sanfilippo F. Transplant Proc; 1993 Oct 15; 25(5):2848-9. PubMed ID: 8212257 [No Abstract] [Full Text] [Related]
28. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. Basta M, Kirshbom P, Frank MM, Fries LF. J Clin Invest; 1989 Dec 15; 84(6):1974-81. PubMed ID: 2687331 [Abstract] [Full Text] [Related]
30. Mechanisms of protection from humoral rejection by a xenografted liver. Celli S, Valdivia LA, Kelly RH, Sun H, Tsugita M, Pan F, Rao AS, Demetris AJ, Fung JJ, Starzl TE. Transplant Proc; 1995 Feb 15; 27(1):300-2. PubMed ID: 7533395 [No Abstract] [Full Text] [Related]
33. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914. Lam TT, Hausen B, Boeke-Purkis K, Paniagua R, Lau M, Hook L, Berry G, Higgins J, Duthaler RO, Katopodis AG, Robbins R, Reitz B, Borie D, Schuurman HJ, Morris RE. Xenotransplantation; 2004 Nov 15; 11(6):517-24. PubMed ID: 15479461 [Abstract] [Full Text] [Related]
34. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts. Pruitt SK, Baldwin WM, Barth RN, Sanfilippo F. Transplantation; 1993 Dec 15; 56(6):1318-24. PubMed ID: 8278996 [Abstract] [Full Text] [Related]
35. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models. Wu GD, Cramer DV, Chapman FA, Wang HK, Chien K, Cole J, Makowka L. Transplant Proc; 1993 Feb 15; 25(1 Pt 1):464-5. PubMed ID: 8438380 [No Abstract] [Full Text] [Related]
36. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L. J Heart Lung Transplant; 1994 Feb 15; 13(3):489-97. PubMed ID: 8061026 [Abstract] [Full Text] [Related]
37. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum. Walpen AJ, Laumonier T, Aebi C, Mohacsi PJ, Rieben R. Xenotransplantation; 2004 Mar 15; 11(2):141-8. PubMed ID: 14962276 [Abstract] [Full Text] [Related]
38. Busulfan depletes neutrophils and delays accelerated acute rejection of discordant xenografts in the guinea pig-to-rat model. Brauer RB, Beck T, Stehle I, Kremer M, Heidecke CD. Transpl Int; 2003 Jan 15; 16(1):37-44. PubMed ID: 12545340 [Abstract] [Full Text] [Related]
39. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives]. Malassagne B, Calmus Y, Houssin D, Weill B. Pathol Biol (Paris); 2000 May 15; 48(4):377-82. PubMed ID: 10868402 [Abstract] [Full Text] [Related]
40. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1995 Feb 15; 27(1):305-6. PubMed ID: 7879012 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]